Patents Assigned to Cryopharm Corporation
-
Patent number: 5516629Abstract: A method for photoinactivating viral and/or bacterial contaminants in blood, blood products or cell cultures is presented. The blood, blood product or cell culture is mixed with an halogenated coumarin sensitizer and irradiated with UV light to inactivate the viral and/or bacterial contaminants.Type: GrantFiled: September 22, 1994Date of Patent: May 14, 1996Assignee: Cryopharm CorporationInventors: Sang C. Park, Raymond P. Goodrich, Jr., Nagender Yerram, Samuel O. Sowemimo-Coker, Matthew S. Platz, Brian M. Aquila
-
Patent number: 5425951Abstract: A process and medium are disclosed for the lyophilization of cells which comprises the use of solutions including monosaccharide hexoses and pentoses, and/or biocompatible amphipathic polymers to permit the reconstitution of viable cells.Type: GrantFiled: May 31, 1991Date of Patent: June 20, 1995Assignee: Cryopharm CorporationInventors: Raymond P. Goodrich, Jr., Christine M. Williams
-
Patent number: 5418130Abstract: A method is provided for inactivating viral and/or bacterial contamination in blood cellular matter, such as erythrocytes and platelets, or protein fractions. The cells or protein fractions are mixed with chemical sensitizers and irradiated with, for example, UV, visible, gamma or X-ray radiation. In particular, quaternary ammonium or phosphonium substituted, halo-psoralen compounds are described as being useful.Type: GrantFiled: July 13, 1993Date of Patent: May 23, 1995Assignee: Cryopharm CorporationInventors: Matthew S. Platz, Raymond P. Goodrich, Jr., Nagendar Yerram
-
Patent number: 5342752Abstract: A method is provided for inactivating viral and/or bacterial and/or parasitic contamination in cellular blood matter or blood plasma protein fractions, using radiation sensitizing chemical compounds and irradiation with, for example, UV radiation.Type: GrantFiled: April 16, 1991Date of Patent: August 30, 1994Assignee: Cryopharm CorporationInventors: Matthew S. Platz, Raymond P. Goodrich, Jr., Victoria A. Wong
-
Patent number: 5257983Abstract: A lyophilization bag is provided in which a fluid, such as blood, may be introduced, lyophilized without collapsing the bag, stored, reconstituted and distributed from the bag without intermediate transfer of the useful contents from the bag.Type: GrantFiled: April 12, 1991Date of Patent: November 2, 1993Assignee: Cryopharm CorporationInventors: Tina K. Garyantes, Daniel F. Jones, Hardin Gilbert, Miller Cho
-
Patent number: 5213814Abstract: A process and medium are disclosed for the lyophilization of cells, specifically platelets, and cell-like matter, which comprises the use of solutions including monosaccharide hexoses and pentoses, and biocompatible amphipathic polymers to permit the reconstitution of transfusably useful cells, specifically platelets, and cell-like matter.Type: GrantFiled: May 17, 1990Date of Patent: May 25, 1993Assignee: Cryopharm CorporationInventors: Raymond P. Goodrich, Jr., Victoria A. Wong
-
Patent number: 5178884Abstract: A process and medium are disclosed for the lyophilization of red blood cells which comprises the use of solutions including monosaccharide hexoses and pentoses, and biocompatible amphipathic polymers to permit the reconstitution of viable red blood cells. Also disclosed are lyophilized and reconstituted erythrocyte and hemosome containing compositions.Type: GrantFiled: June 29, 1989Date of Patent: January 12, 1993Assignee: Cryopharm CorporationInventors: Raymond P. Goodrich, Christine M. Williams, Roger W. Hackett
-
Patent number: 5171661Abstract: A process and medium are disclosed for the lyophilization of red blood cells which comprises the use of solutions including monosaccharide hexoses and pentoses, and/or biocompatible polymers to permit the reconstitution of viable red blood cells.Type: GrantFiled: July 31, 1990Date of Patent: December 15, 1992Assignee: Cryopharm CorporationInventors: Raymond P. Goodrich, Jr., Christine M. Williams
-
Patent number: 5153004Abstract: A process and medium are disclosed for the freezing of red blood cells which comprises the use of solutions including monosaccharide hexoses and pentoses, and/or biocompatible amphipathic polymers to permit the thawing without washing to produce viable red blood cells.Type: GrantFiled: April 5, 1990Date of Patent: October 6, 1992Assignee: Cryopharm CorporationInventors: Raymond P. Goodrich, Jr., Christine M. Williams
-
Patent number: 5045446Abstract: A process and medium are disclosed for the lyophilization of cells which comprises the use of solutions including monosaccharide hexoses and pentoses, and/or biocompatible amphipathic polymers to permit the reconstitution of viable cells.Type: GrantFiled: July 11, 1989Date of Patent: September 3, 1991Assignee: Cryopharm CorporationInventors: Raymond P. Goodrich, Jr., Christine M. Williams
-
Patent number: 5043261Abstract: A process and medium are disclosed for the lyophilization of red blood cells which comprises the use of solutions including monosaccharide hexoses and pentoses, and biocompatible polymers to permit the reconstitution of viable red blood cells.Type: GrantFiled: June 2, 1989Date of Patent: August 27, 1991Assignee: Cryopharm CorporationInventors: Raymond Goodrich, Christine Williams
-
Patent number: 4874690Abstract: A process and medium are disclosed for the lyophilization of red blood cells which comprises the use of solutions including monosaccharide hexoses and pentoses, biocompatible polymers and polyanions to permit the reconstitution of viable red blood cells.Type: GrantFiled: August 26, 1988Date of Patent: October 17, 1989Assignee: Cryopharm CorporationInventors: Raymond P. Goodrich, Jr., Christine M. Williams, Robert S. Franco, Murray Weiner